Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikko Gynther

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Pharmaceutical Research|October 14, 2021
The Effect of Single Nucleotide Variations in the Transmembrane Domain of OATP1B1 on in vitro FunctionalityWilma Kiander, Kati-Sisko Vellonen, Melina M Malinen, et al.
Scientific Reports|June 23, 2021
Metabolomic and lipidomic changes triggered by lipopolysaccharide-induced systemic inflammation in transgenic APdE9 miceElena Puris, Štěpán Kouřil, Lukáš Najdekr, et al.
Pharmaceutical Research|November 30, 2018
Alzheimer's Disease Phenotype or Inflammatory Insult Does Not Alter Function of L-Type Amino Acid Transporter 1 in Mouse Blood-Brain Barrier and Primary AstrocytesMikko Gynther, Elena Puris, Soile Peltokangas, et al.
Pharmaceutics|November 11, 2022
Increased Expression and Activity of Brain Cortical cPLA2 Due to Chronic Lipopolysaccharide Administration in Mouse Model of Familial Alzheimer's DiseaseMikko Gynther, Mariana Leal Estrada, Sanna Loppi, et al.
Molecular Cancer Therapeutics|October 30, 2014
Evaluation of novel imidazotetrazine analogues designed to overcome temozolomide resistance and glioblastoma regrowthYulian P Ramirez, Ann C Mladek, Roger M Phillips, et al.
Journal of Pharmaceutical Sciences|March 28, 2025
In vitro characterization of SLCO2B1 genetic variantsAlli Sinokki, Annika Miinalainen, Saara Kivioja, et al.
Neurochemical Research|August 23, 2017
Effects of Dimeric PSD-95 Inhibition on Excitotoxic Cell Death and Outcome After Controlled Cortical Impact in RatsJens Bak Sommer, Anders Bach, Hana Malá, et al.
Chemmedchem|September 11, 2014
Quantitative insight into the design of compounds recognized by the L-type amino acid transporter 1 (LAT1)Henna Ylikangas, Kalle Malmioja, Lauri Peura, et al.
Neuroscience|May 31, 2022
Metabolomic, Lipidomic and Proteomic Characterisation of Lipopolysaccharide-induced Inflammation Mouse ModelElena Puris, Štěpán Kouřil, Lukáš Najdekr, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2016
In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Pharmaceutical Research|October 14, 2021
The Effect of Single Nucleotide Variations in the Transmembrane Domain of OATP1B1 on in vitro FunctionalityWilma Kiander, Kati-Sisko Vellonen, Melina M Malinen, et al.
Scientific Reports|June 23, 2021
Metabolomic and lipidomic changes triggered by lipopolysaccharide-induced systemic inflammation in transgenic APdE9 miceElena Puris, Štěpán Kouřil, Lukáš Najdekr, et al.
Pharmaceutical Research|November 30, 2018
Alzheimer's Disease Phenotype or Inflammatory Insult Does Not Alter Function of L-Type Amino Acid Transporter 1 in Mouse Blood-Brain Barrier and Primary AstrocytesMikko Gynther, Elena Puris, Soile Peltokangas, et al.
Pharmaceutics|November 11, 2022
Increased Expression and Activity of Brain Cortical cPLA2 Due to Chronic Lipopolysaccharide Administration in Mouse Model of Familial Alzheimer's DiseaseMikko Gynther, Mariana Leal Estrada, Sanna Loppi, et al.
Molecular Cancer Therapeutics|October 30, 2014
Evaluation of novel imidazotetrazine analogues designed to overcome temozolomide resistance and glioblastoma regrowthYulian P Ramirez, Ann C Mladek, Roger M Phillips, et al.
Journal of Pharmaceutical Sciences|March 28, 2025
In vitro characterization of SLCO2B1 genetic variantsAlli Sinokki, Annika Miinalainen, Saara Kivioja, et al.
Neurochemical Research|August 23, 2017
Effects of Dimeric PSD-95 Inhibition on Excitotoxic Cell Death and Outcome After Controlled Cortical Impact in RatsJens Bak Sommer, Anders Bach, Hana Malá, et al.
Chemmedchem|September 11, 2014
Quantitative insight into the design of compounds recognized by the L-type amino acid transporter 1 (LAT1)Henna Ylikangas, Kalle Malmioja, Lauri Peura, et al.
Neuroscience|May 31, 2022
Metabolomic, Lipidomic and Proteomic Characterisation of Lipopolysaccharide-induced Inflammation Mouse ModelElena Puris, Štěpán Kouřil, Lukáš Najdekr, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2016
In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, et al.
Pageof 6